Author:
Mohammadi Hadi Share,Asl Ali Haghighi,Khajenoori Maryam
Reference59 articles.
1. 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial;Hickok;Lancet Oncol.,2005
2. Prevalence and severity of acute and delayed NV association with 3 highly emetogenic chemotherapies;Hickok;Support. Care Cancer,2001
3. Cancer patients' expectations of experiencing treatment-related side effects;Hofman;Cancer,2004
4. Side effects and emotional distress during cancer chemotherapy;Love;Cancer,1989
5. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis;Cocquyt;Eur. J. Cancer,2001